Weijun Biotechnology (00660) delayed publication of 2026 annual results and suspended from October 2

Zhitong Finance App News, Weijun Biotechnology (00660) issued an announcement. Due to the additional time required by the company and auditors to complete the audit work, the company is unable to publish the 2026 annual results on or before September 30, 2026 in accordance with section 13.49 (1) of the listing rules. The company is working closely with the auditor to provide all necessary information and documents to complete the audit process as soon as possible. However, further discussions with the auditors will be required to determine the expected release date of the annual results, and announcements will be made in due course.

According to section 13.50 of the listing rules, if an issuer fails to publish regular financial information in accordance with the listing rules, the Hong Kong Stock Exchange will usually request the suspension of trading of the issuer's securities, and the suspension of trading will usually continue until the issuer publishes an announcement containing the required financial information.

According to the listing rules, if the 2026 results are not published before September 30, 2026, it is expected that trading of the company's shares will be suspended on the Stock Exchange, effective from 9:00 a.m. on the next business day after the deadline (i.e. October 2, 2026).